Statistics

	Views
Symptoms and medication scores results in the ALUMITES study, a randomised, controlled, multicenter phase IV study with house dust mites subcutaneous immunotherapy for allergic rhinitis. Six months interim analysis	80

Select a period of time:

	Views
Symptoms and medication scores results in the ALUMITES study, a randomised, controlled, multicenter phase IV study with house dust mites subcutaneous immunotherapy for allergic rhinitis. Six months interim analysis	20

RUNA digital repository